317 related articles for article (PubMed ID: 24177261)
21. Endocrine effects of chemicals: aspects of hazard identification and human health risk assessment.
Dekant W; Colnot T
Toxicol Lett; 2013 Dec; 223(3):280-6. PubMed ID: 23542818
[TBL] [Abstract][Full Text] [Related]
22. Human exposure to endocrine disrupting compounds: Their role in reproductive systems, metabolic syndrome and breast cancer. A review.
Giulivo M; Lopez de Alda M; Capri E; Barceló D
Environ Res; 2016 Nov; 151():251-264. PubMed ID: 27504873
[TBL] [Abstract][Full Text] [Related]
23. An Informatics Approach to Evaluating Combined Chemical Exposures from Consumer Products: A Case Study of Asthma-Associated Chemicals and Potential Endocrine Disruptors.
Gabb HA; Blake C
Environ Health Perspect; 2016 Aug; 124(8):1155-65. PubMed ID: 26955064
[TBL] [Abstract][Full Text] [Related]
24. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS).
Melching-Kollmuss S; Bothe K; Charlton A; Gangadharan B; Ghaffari R; Jacobi S; Marty S; Marxfeld HA; McInnes EF; Sauer UG; Sheets LP; Strupp C; Tinwell H; Wiemann C; Botham PA; van Ravenzwaay B
Crit Rev Toxicol; 2023 Jul; 53(6):339-371. PubMed ID: 37554099
[TBL] [Abstract][Full Text] [Related]
25. [The concept of endocrine disruption and human health].
Cravedi JP; Zalko D; Savouret JF; Menuet A; Jégou B
Med Sci (Paris); 2007 Feb; 23(2):198-204. PubMed ID: 17291431
[TBL] [Abstract][Full Text] [Related]
26. Early neuroendocrine disruption in hypothalamus and hippocampus: developmental effects including female sexual maturation and implications for endocrine disrupting chemical screening.
Bourguignon JP; Franssen D; Gérard A; Janssen S; Pinson A; Naveau E; Parent AS
J Neuroendocrinol; 2013 Nov; 25(11):1079-87. PubMed ID: 24028442
[TBL] [Abstract][Full Text] [Related]
27. Endocrine disrupting chemicals: exposure, effects on human health, mechanism of action, models for testing and strategies for prevention.
Yilmaz B; Terekeci H; Sandal S; Kelestimur F
Rev Endocr Metab Disord; 2020 Mar; 21(1):127-147. PubMed ID: 31792807
[TBL] [Abstract][Full Text] [Related]
28. Impact of endocrine disruptor chemicals in gynaecology.
Caserta D; Maranghi L; Mantovani A; Marci R; Maranghi F; Moscarini M
Hum Reprod Update; 2008; 14(1):59-72. PubMed ID: 18070835
[TBL] [Abstract][Full Text] [Related]
29. Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound.
Lagadic L; Katsiadaki I; Biever R; Guiney PD; Karouna-Renier N; Schwarz T; Meador JP
Rev Environ Contam Toxicol; 2018; 245():65-127. PubMed ID: 29119384
[TBL] [Abstract][Full Text] [Related]
30. What is an endocrine disruptor?
Monneret C
C R Biol; 2017; 340(9-10):403-405. PubMed ID: 29126512
[TBL] [Abstract][Full Text] [Related]
31. Environmental non-persistent endocrine-disrupting chemicals exposure and reproductive hormones levels in adult men.
Dziewirska E; Hanke W; Jurewicz J
Int J Occup Med Environ Health; 2018 Oct; 31(5):551-573. PubMed ID: 30228382
[TBL] [Abstract][Full Text] [Related]
32. Possible relationship between endocrine disrupting chemicals and hormone dependent gynecologic cancers.
Dogan S; Simsek T
Med Hypotheses; 2016 Jul; 92():84-7. PubMed ID: 27241264
[TBL] [Abstract][Full Text] [Related]
33. Multiple Endocrine Disrupting Effects in Rats Perinatally Exposed to Butylparaben.
Boberg J; Axelstad M; Svingen T; Mandrup K; Christiansen S; Vinggaard AM; Hass U
Toxicol Sci; 2016 Jul; 152(1):244-56. PubMed ID: 27122241
[TBL] [Abstract][Full Text] [Related]
34. Report from the BfR expert hearing on practicability of hormonal measurements: recommendations for experimental design of toxicological studies with integrated hormonal end points.
Kucheryavenko O; Lurman G; Lehmann A; Braz J; Niemann L; Chahoud I; Mantovani A; Håkansson H; Schneider S; Strauss V; Coder PS; Freyberger A; O'Connor JC; Rauch M; Renko K; Solano MLM; Andersson N; Blanck O; Ritz V; Solecki R
Arch Toxicol; 2019 Apr; 93(4):1157-1167. PubMed ID: 30929029
[TBL] [Abstract][Full Text] [Related]
35. European Union's strategy on endocrine disrupting chemicals and the current position of Slovenia.
Perharič L; Fatur T; Drofenik J
Arh Hig Rada Toksikol; 2016 Jun; 67(2):99-105. PubMed ID: 27331297
[TBL] [Abstract][Full Text] [Related]
36. Disruption of rat testis development following combined in utero exposure to the phytoestrogen genistein and antiandrogenic plasticizer di-(2-ethylhexyl) phthalate.
Jones S; Boisvert A; Duong TB; Francois S; Thrane P; Culty M
Biol Reprod; 2014 Sep; 91(3):64. PubMed ID: 25031359
[TBL] [Abstract][Full Text] [Related]
37. Endocrine disrupting chemicals: effects on human male reproductive health.
Murray TJ; Lea RG; Abramovich DR; Haites NE; Fowler PA
Early Pregnancy (Cherry Hill); 2001 Apr; 5(2):80-112. PubMed ID: 11753523
[TBL] [Abstract][Full Text] [Related]
38. NTP toxicity report of reproductive dose range-finding study of Genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats.
Delclos KB; Newbold R
Toxic Rep Ser; 2007 Nov; (79):1-C2. PubMed ID: 18685712
[TBL] [Abstract][Full Text] [Related]
39. In utero exposure to the oestrogen mimic diethylstilbestrol disrupts gonadal development in a viviparous reptile.
Parsley LM; Wapstra E; Jones SM
Reprod Fertil Dev; 2015 Sep; 27(7):1106-14. PubMed ID: 24718097
[TBL] [Abstract][Full Text] [Related]
40. Human exposure to endocrine disruptors and breast milk.
Stefanidou M; Maravelias C; Spiliopoulou C
Endocr Metab Immune Disord Drug Targets; 2009 Sep; 9(3):269-76. PubMed ID: 19594415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]